Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Global Bioenergy UCITS ETF USD Acc
CWEG · LU1681046188 · class UCITS ETF USD Acc · USD · domicile Luxembourg
Equity · Global · Sustainable / ESG · ThematicSFDR art. 8
Index tracked: Bloomberg BioEnergy Screened Index
- TER
- 0.35%+ trans. 0.05%
- Fund size
- 5 m EUR
- Tracking difference
- +0.08%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Accumulating
Launch 30 Jan 2018 · costs from the KID as of 2 Sept 2026 · 26 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg BioEnergy Screened Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the Index constituents are included in the Index return. The Index is constructed to track the…
Performance since series start (in euro) — base 100
31 Jan 2018 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +56.1% |
| 3 years | +36.9% |
| 5 years | +151.0% |
| 10 years | series too young |
| Since series start | +100.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 15.70% | 15.59% | 20.58% |
| Max drawdown | −7.83% | −31.15% | −33.33% |
| Sharpe | 2.72 | 0.68 | 0.85 |
| Sortino | 4.44 | 0.97 | 1.21 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CWEG · LU16810461881
RebalixCWEG · LU1681046188 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +23.77% | +23.54% | +0.22% |
| 2024 | −20.06% | −20.27% | +0.22% |
| 2023 | +0.59% | +0.78% | −0.19% |
| 2022 | +45.55% | +46.01% | −0.45% |
| 2021 | +39.28% | +40.09% | −0.81% |
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 26 securities · top-10 weight = 77.7%
| Top holdings | Weight |
|---|---|
| 10.1% | |
| 9.9% | |
| 9.7% | |
| 8.3% | |
| 7.9% | |
| 7.9% | |
| 6.9% | |
| 6.6% | |
| 6.5% | |
| 3.9% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
X136 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 18 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1681046188
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1681046188
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CWEG · LU16810461882